Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.

NCT00043459 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: intravenous T900607-sodium

Sponsor

Tularik